Sermorelin vs Ipamorelin vs Tesamorelin: Quick Comparison Sermorelin, ipamorelin, and tesamorelin all increase the secretion of growth hormone (GH) from the pituitary gland, but they fall into two different peptide families that reach that result through different receptors
Moreover, when mice were pre-treated with vehicle or L2-Cmu (20 mg/kg) by intraperitoneal (i.p.) injection, and then challenged with an intravenous (i.v.) bolus of saline or 5 g IGF-1, L2-Cmu was able to modulate IGF-1R activation in vivo, as demonstrated by a near complete inhibition of IGF-1R phosphorylation in lung and ~70% inhibition in heart (Fig
Sikiri, P., Petek, M., Ruman, R., Seiwerth, S., Grabarevi, Z., Rotkvi, I., Turkovi, B., Jagi, V., Mildner, B., Duvnjak, M., Lang, N., Danilovi, Z., Cviko, A., Kolega, M., Sallmani, A., Djai, S., Bura, M., Brki, T., Bani, M.,
Cagrilintide acts as a potent agonist at amylin receptors, which are heterodimeric complexes of the calcitonin receptor (CTR) and receptor activity-modifying proteins (RAMPs), primarily RAMP1, RAMP2, and RAMP3
It has advanced further into clinical development than GHK-Cu for therapeutic indications, with Phase II/III programs reported
PMC 4063985